IDEXX beats Q1 earnings and revenue forecasts, raises 2021 guidance

IDEXX Laboratories Inc. (Nasdaq: IDXX) on Tuesday posted first-quarter results that surpassed market forecasts and raised its 2021 outlook to reflect expectations for higher organic revenue growth and better operating margins.

The Westbrook-based provider of veterinary diagnostics, veterinary practice software and water microbiology testing said that first-quarter revenue was $778 million, an increase of 24% on a reported basis and 21% higher organically over a year earlier. That exceeded the consensus forecast of analysts polled by Zacks Investment Research by 5.87%. Read more

Related Posts

Bangor will be abuzz with Maine science at annual festival

The Maine Science Festival’s headlining event will be a major collaboration with a local arts organization for the second year in...

23 March 2023

Report: National Institutes of Health added $264M to Maine economy in 2022

The National Institutes of Health supported 1,950 jobs and $264 million in economic activity in Maine during 2022 through $112.7 million in grants and...

22 March 2023

Northern Light completes deal to outsource diagnostics to Quest

Quest Diagnostics (NYSE: DGX), a Secaucus, N.J.-based diagnostic information services provider with a national footprint, said Monday that it has completed the acquisition...

21 March 2023